Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening

Benzinga_recent_news04-24 16:17

The rebrand caps a fundamental strategic pivot, exiting consumer medical devices and repositioning around Entolimod™, a TLR5 agonist developed as a medical countermeasure for acute radiation syndrome,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2629981909?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/24/A-Close-up--Blurred-View-Of-A-Digital-Sc.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-04-24 16:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2629981909","market":"sh","top_or_hot":-1,"title":"Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening","media":"Benzinga_recent_news","content":"<div>\n<p>The rebrand caps a fundamental strategic pivot, exiting consumer medical devices and repositioning around Entolimod™, a TLR5 agonist developed as a medical countermeasure for acute radiation syndrome,...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/04/52022779/tivic-health-systems-tivc-stock-surges-over-24-after-hours-heres-what-is-happening\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-24 16:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/26/04/52022779/tivic-health-systems-tivc-stock-surges-over-24-after-hours-heres-what-is-happening><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The rebrand caps a fundamental strategic pivot, exiting consumer medical devices and repositioning around Entolimod™, a TLR5 agonist developed as a medical countermeasure for acute radiation syndrome,...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/04/52022779/tivic-health-systems-tivc-stock-surges-over-24-after-hours-heres-what-is-happening\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RSI","symbol_name":"Rush Street Interactive, Inc.","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/26/04/52022779/tivic-health-systems-tivc-stock-surges-over-24-after-hours-heres-what-is-happening","article_id":"2629981909","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/24/A-Close-up--Blurred-View-Of-A-Digital-Sc.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/04/52022779/tivic-health-systems-tivc-stock-surges-over-24-after-hours-heres-what-is-happening","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2629981909","pubTimestamp":1777018620,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Tivic Health Systems Inc. shares rise 24.10% after hours after announcing a full rebrand to Valion Bio and a strategic pivot toward Entolimod-based immunotherapy development.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RSI":"Rush Street Interactive, Inc.","BK4082":"医疗保健设备","BK4150":"赌场与赌博","TIVC":"Tivic Health Systems, Inc."},"translate_title":"Tivic Health Systems(TIVC)股价盘后飙升超过24%：事情如下","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TIVC":1.5,"RSI":1},"content_text":"The rebrand caps a fundamental strategic pivot, exiting consumer medical devices and repositioning around Entolimod™, a TLR5 agonist developed as a medical countermeasure for acute radiation syndrome, with Food and Drug Administration Fast Track and Orphan Drug designations. The asset is advancing under the FDA’s Animal Rule pathway, which permits approval based on animal efficacy data when human trials are not feasible or ethical.\nValion Bio is actively engaging the Biomedical Advanced Research and Development Authority (BARDA), the Defense Threat Reduction Agency (DTRA), and the National Institute of Allergy and Infectious Diseases (NIAID) regarding Entolimod’s inclusion in the U.S. Strategic National Stockpile— a procurement contract the company says could represent a non-dilutive, nine-figure revenue event.\nTivic Health, a late-stage immunotherapeutics company, has a market capitalization of $3.22 million, with a 52-week high of $7.74 and a 52-week low of $0.72.\nThe Relative Strength Index (RSI) of TIVC stands at 56.26.\nThe small-cap stock has dropped 84.09% over the past 12 months.\nCurrently, the stock is positioned at about 5.7% above its 52-week low, meaning it is still trading near the lower end of its yearly range.\nPrice Action: Tivic closed the regular session down 1.75% at $1.12, according to Benzinga Pro.\nBenzinga's Edge Stock Rankings indicate that TIVC is experiencing long-term consolidation along with medium and short-term upward movement.\nPhoto Courtesy: abunuh051992 on Shutterstock.com\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2629981909","isCrawlerRequest":true}